-
Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease
-
Model Innovation in Parkinson’s disease drug development: linking Quantitative Systems Pharmacology to the patient voice
-
Modeling of the Placebo Response in Parkinson’s Disease
-
Molecular changes of a de novo missense variant in VPS16 in dystonia
-
Molecular investigation of apparently healthy heterozygous Parkin mutation carriers
-
MOLECULAR-GENETIC ASPECTS OF WILSON’S DISEASE IN UKRAINE
-
Monitoring electrophysiological parameters in PD patients enrolled for MRgFUS: l’Aquila-tor Vergata experience
-
Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): The 500-genomes pilot project
-
Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)
-
Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 132
- Next Page »